ADVISORS PREFERRED, LLC – Halozyme Therapeutics, Inc. Transaction History
ADVISORS PREFERRED, LLC portfolio value:
$317,000
portfolio value
ADVISORS PREFERRED, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.63% | -131 shares | -38K | $39.54 | 7.92K |
| Q2 2022 | share | Decrease | -26.32% | -2.87K shares | -100K | $44 | 8.05K |
| Q1 2022 | share | Increase | 0.00% | 10.93K shares | 455K | $39.88 | 10.93K |
| Q2 2021 | share | Decrease | -100.00% | -68.27K shares | -2.89M | $45.41 | 0 |
| Q1 2021 | share | Increase | +75.17% | 29.29K shares | 1.24M | $41.69 | 68.27K |
| Q4 2020 | share | Increase | 0.00% | 38.97K shares | 1.65M | $42.71 | 38.97K |